Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of a Recombinant Humanized mAb Specific to B-and T-Lymphocyte Attenuator (BTLA) for Injection in Subjects With Advanced Malignancies [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics of a recombinant humanized anti-BTLA monoclonal antibody in patients with…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of APG-2449 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, esophageal…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Safety of AM-928 Infusion in Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial update on the safety of AM-928 infusion in patients with advanced solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating SHR-7631 for injection in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: National Project on Vaccines, COVID-19 and Frail Patients
The trial update reports the completion of a national project evaluating COVID-19 vaccines in frail patients, including those with solid tum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors. [Phase 1]
Chiome Bioscience is conducting a Phase 1, first-in-human trial of CBA-1535, a 5T4/CD3 bispecific T cell engager, in patients with advanced …
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease [NA]
A clinical trial is evaluating the Go Wish Game to promote advance care planning in patients with leukemia, multiple myeloma, and other onco…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of DCTY1102 Injection in patients with advanced solid tumors, including pancreatic ductal adenocarcinoma, colorectal cancer, n…
-
CLINICAL_TRIALS research · 2025-06-09Clinical Trial Update: A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas [Phase 1]
This clinical trial update reports that ATG-031 is being studied in a Phase 1 trial for patients with advanced solid tumors or B-cell non-Ho…
-
CLINICAL_TRIALS other · 2025-06-09Clinical Trial Update: A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas [Phase 1]
A Phase 1 study of ATG-101 in patients with metastatic/advanced solid tumors and mature B-cell non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS other · 2025-06-05Clinical Trial Update: Expanded Access of Vigil in Solid Tumors
The expanded access program for Vigil in solid tumors, including Ewing sarcoma, is temporarily not available.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors [Phase 1]
An ongoing Phase 1 study evaluating BL-M09D1 in patients with locally advanced or metastatic gastrointestinal cancers and other solid tumors…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Real-life Performance Evaluation of the LiFlow X-ray Platform
This trial update outlines a real-world performance evaluation of the LiFlow X-ray platform in solid tumors, with recruitment not yet starte…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) [Phase 1]
Phase 1 trial update of favezelimab (MK-4280) as monotherapy or in combination with pembrolizumab (MK-3475), with or without chemotherapy or…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors [Phase 1]
A Phase 1 study of SGT-53 in children with refractory or recurrent solid tumors has been suspended.
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 safety and tolerability trial update for T-1201 in patients with advanced solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies [Phase 1]
Phase 1 trial update of RTA 402 (bardoxolone methyl) in patients with advanced solid tumors or lymphoid malignancies; the study has complete…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics, and antitumor activity of ADCT-901 in participants with sele…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
An Expanded Access Program update for MNPR-101-DFO*-89Zr in patients with solid tumors, sponsored by Monopar Therapeutics; the program is cu…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis
This clinical trial update notes the completed study assessing the impact of MANNA's Medically Tailored Meal Program in patients with non-te…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors [Phase 1]
Phase 1 study of Mipasetamab Uzoptirine (ADCT-601) in participants with solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM) [NA]
A feasibility study to evaluate a decentralised care pathway coordinated by an Advanced Practice Nurse for patients with solid tumors or hem…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports that CFI-402257, a potent and selective TTK inhibitor, is being studied in Phase 1/Phase 2 trials for adv…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors [Phase 1]
Relay Therapeutics' first-in-human Phase 1 study of RLY-5836 in advanced breast cancer and other solid tumors has completed.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update for Tulmimetostat DZR123 (CPI-0209) in adults with advanced solid tumors and various lymphomas. The study is in Phase …